Calyxt to Present at the H.C. Wainwright 24th Annual Global Investment Conference
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Calyxt, a plant-based synthetic biology company (Nasdaq: CLXT), announced that its CEO Michael A. Carr and CFO Bill Koschak will present at the H.C. Wainwright 24th Annual Global Investment Conference from September 12-14, 2022. Their presentation is scheduled for September 13 at 2:30 p.m. ET, and a webcast is available here. Attendees can also arrange 1:1 meetings. More details and the presentation replay can be found on Calyxt's website.
Details
News Market Reaction – CLXT
The recorded move for CLXT in the trading session of this news was -0.47%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
ROSEVILLE, Minn., Sept. 7, 2022 /PRNewswire/ -- Calyxt, Inc. (Nasdaq: CLXT), a plant-based synthetic biology company, today announced that Michael A. Carr, President and Chief Executive Officer, and Bill Koschak, Chief Financial Officer, will present at the H.C Wainwright 24th Annual Global Investment Conference taking place September 12-14, 2022.
H.C. Wainwright 24th Annual Global Investment Conference
Date: Tuesday, September 13, 2022
Time: 2:30 p.m. ET
Webcast: https://journey.ct.events/view/89f76b34-90f0-4836-b94b-90b001e47b2a
Management is also available for 1:1 meetings during the conference. Conference attendees should reach out to the event organizers or investors@calyxt.com to schedule.
The presentation will be available for viewing and replay from the Investors section of Calyxt's website at www.calyxt.com.
Calyxt (Nasdaq: CLXT) is a plant-based synthetic biology company. The Company leverages its proprietary PlantSpring™ technology platform to engineer plant metabolism to produce innovative high value plant-based chemistries for use in customers' materials and products. As plant-based solutions, the Company's synthetic biology products can be used in helping customers meet their sustainability targets and financial goals. Calyxt's diversified offerings are primarily delivered through its proprietary BioFactory™ production system. For more information, visit www.calyxt.com.
PlantSpring, BioFactory, Plant Cell Matrix™, and the Calyxt logo are trademarks of Calyxt, Inc. Any other trademarks belong to their respective owners.
Contacts:
Calyxt Media Contact: | Calyxt Investor Relations Contact: |
Brennan Burks Calyxt, Inc. (651) 724-5788
| Kimberly Minarovich/ Cameron Willis Argot Partners (212) 600-1902
|
View original content to download multimedia:https://www.prnewswire.com/news-releases/calyxt-to-present-at-the-hc-wainwright-24th-annual-global-investment-conference-301618955.html
SOURCE Calyxt, Inc.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
